开发具有强大抗白血病效力的口服生物可用FTO抑制剂
Teng Yang1,2, Ze Dong1,2, Rong Du1,2,3
1School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
Journal of medicinal chemistry
|June 28, 2025
概括
一种新药,Dac590,有效地抑制FTO酶,通过减少癌细胞生长和改善小鼠模型的生存率,显示出治疗急性髓性白血病 (AML) 的前景.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 甲基氨酸 (m6A) 是一种由FTO脱甲酶调节的关键mRNA修饰.
- 异常的FTO过度表达驱动急性髓性白血病 (AML) 的白血病发生.
研究的目的:
- 开发一种强效,口服可生物利用的FTO抑制剂,用于AML治疗.
- 在AML模型中评估新型抑制剂Dac590的疗效和安全性.
主要方法:
- 对FTO抑制剂的结构导向优化导致了Dac590.0的开发.
- 在AML细胞系中评估了抗增殖效应.
- 活体疗效在AML异种移植小鼠模型中进行了评估.
- 研究了与德西他的协同效应.
主要成果:
- Dac590表现出强大的FTO抑制活性和改善的药理动力学特性.
- Dac590通过抑制FTO信号,对AML细胞表现出强大的抗增殖作用.
- 在没有毒性的AML小鼠模型中,口服Dac590显著抑制了瘤生长和延长了生存时间.
- 达克590与德西他协同作用,增强DNA低甲基化和提高生存率.
结论:
- Dac590是一种强效,口服生物可用的FTO抑制剂,对AML具有显著的治疗潜力.
- 使用Dac590和decitabine的组合疗法为通过双重表观遗传调制增强AML治疗提供了一个有希望的策略.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


